| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |